LifeStyle
-
LG Chem leads project to recover resource in cement production
SEOUL -- South Korean cement companies are expanding the use of waste plastic with high bio-mass content as an alternative fuel to reduce greenhouse gas emissions from the heating of limestone, the burning of fossil fuels, and a chemical process called calcination. Burning waste plastics produces chlorine dust, a byproduct that cannot be recycled. Chlorine components attached to the walls of cement preheaters also reduce the utilization of production facilities. LG Chem tied up wit
30 June 2022
-
S. Korea's first homemade COVID-19 vaccine secures final state approval for manufacturing and sales
SEOUL -- South Korea's first homemade COVID-19 vaccine developed by SK Bioscience secured final state approval for manufacturing and sales at home and abroad. SK Bioscience will seek to get its vaccine listed by the World Health Organization for emergency use. The Ministry of Food and Drug Safety, a government public health agency, said it has approved the manufacturing and sales of SK Bioscience's vaccine codenamed GBP510 as a condition of submitting the final result repor
29 June 2022
-
Silica used for Kolmar Korea's color cosmetics to replace microplastics
SEOUL -- Powder formulations containing microplastics are widely used for the soft application of color cosmetics, but research has been conducted to find alternative materials as microscopic plastic particles have become a serious environmental issue that can have devastating effects on ecosystems and human health. Kolmar Korea, a beauty and cosmetics product maker, has developed a technology that replaces microplastics used in color cosmetics with silica, a natural substance Silic
29 June 2022
-
CGBIO leads state-funded project to develop new negative pressure wound treatment device
SEOUL -- CGBIO, a total healthcare provider in South Korea, has been selected for a state-funded project to develop a new negative pressure wound cleaning and healing device that can regenerate wounds and treat infections at the same time. The project is aimed at enhancing the competitiveness of localized equipment in the global market dominated by foreign companies. Negative pressure wound therapy (NPWT) improves the healing of open nonsurgical wounds using negative pressure for th
27 June 2022
-
Researchers propose practical solution to prevent cross-infection while preserving skin naturalness
SEOUL -- A COVID-19 pandemic has called for the enhanced hygiene of public facilities. The fear of infection prompted the fast adoption of antibacterial materials such as gloves. Antibacterial films and similar materials were widely used to cover elevator buttons, door handles and other objects that are frequently touched by many random people. However, there has been no practical solution to prevent cross-infection while preserving intrinsic skin naturalness. South Korean and Jap
23 June 2022
-
CJ Feed & Care unveils feed capable of reducing dairy cattle's methane emissions
SEOUL -- CJ Feed & Care, a livestock feed corporation affiliated with CJ Cheil Jedang, unveiled an eco-friendly feed that can reduce the amount of methane emitted by dairy cattle by burping or farting. Methane is a greenhouse gas that affects the earth's temperature and climate system. Cows burp out large quantities of heat-trapping methane. Various solutions have been studied to lower the carbon footprint of beef and dairy cattle. Milk cows emit more methane than beef cat
21 June 2022
-
Theragen Bio selected for state project to produce new chips for genomic analysis
SEOUL -- Theragen Bio, a genetic analysis service provider, has been selected for a state project to produce advanced chips for genomic analysis that would be used for identifying the genetic causes of common chronic diseases among Korean people. The Korea Disease Control and Prevention Agency (KDCA), a state health body, has launched a "Korean Chip" project to identify the genetic causes of common chronic diseases by collecting information on genetic variation. A genome
7 June 2022
-
Yuhan works with research teams to develop new drug platforms based on mRNA
SEOUL -- Yuhan, a pharmaceutical and chemical company in South Korea, will push for the development of new drug platform technologies based on messenger ribonucleic acid (mRNA) in cooperation with U.S. and South Koran university research teams. mRNA is a transient intermediator between genes and proteins. It has emerged as a new category of therapeutic agent to prevent and treat various diseases. To function in vivo, mRNA requires safe, effective and stable delivery systems such as
7 June 2022
